PNI Recommendations for Coronavirus (COVID-19)
Dear PNI Patients and Referring Doctors:
In an abundance of caution, and for the protection of our patients and staff, Pacific Neuroscience Institute is implementing temporary measures to help reduce the spread of COVID-19. As this is a rapidly evolving situation, we anticipate the need to modify our approach from time to time, and the duration of these measures remains uncertain.
To comply with CDC recommendations on “social distancing”, effective Monday March 16, 2020, PNI clinics will focus on seeing only those patients deemed urgent or semi-urgent. For example, patients that require cancer treatments or patients presenting with progressively worsening neurologic symptoms or deficits will still be seen.
As our PNI Clinics see patients with a wide spectrum of illness, each clinic and physician has different criteria for clinic visits. However, here is what we recommend:
Patients with urgent or semi-urgent conditions can be seen at the providers discretion. This determination is specialty-specific, and the provider’s office can determine the need for your visit. Patients indicated as essential will be seen at the provider’s discretion.
Non-essential visits will be postponed. These are defined as routine and follow-up appointments that are designated as clinically safe to be rescheduled to a later time by providers.
Prescriptions will still be processed and providers will regularly check to ensure these are approved.
Telehealth/Virtual visits may be utilized as appropriate at the discretion of the provider.
Patient support groups and meetings will be postponed.
We remain committed to protecting our patients, providers, and caregivers.
Thank you for your understanding during this challenging time.
Daniel F. Kelly, MD
Director, Pacific Neuroscience Institute
2125 Arizona Ave.,
Santa Monica, CA 90404
For more information:
- PNI Directory
- Back to Basics: Facts and FAQs About COVID-19
- 3 Things to Know About Multiple Sclerosis and COVID-19
- Managing Stress, Isolation, and Risk of Drug or Alcohol Relapse During the COVID-19 Pandemic
- Parkinson’s Disease: Patient Guide to COVID-19